Judd W Moul

发表

Navigating MRI-TRUS fusion biopsy: optimizing the process and avoiding technical pitfalls

Kae Jack Tay, Rajan T. Gupta, J. Moul, 2016, Expert review of anticancer therapy.

Utility of a 3-Dimensional Transrectal Ultrasound-guided Prostate Biopsy System for Prostate Cancer Detection

J. Moul, J. Madden, V. Mouraviev, 2009, Technology in cancer research & treatment.

Downsides of robot-assisted laparoscopic radical prostatectomy: limitations and complications.

Markus Graefen, Rodolfo Montironi, Tullio Sulser, 2010, European urology.

Androgen-induced expression of endoplasmic reticulum (ER) stress response genes in prostate cancer cells

Wei Zhang, Wei Zhang, J. Moul, 2002, Oncogene.

Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy.

Ming-Hui Chen, Anthony V D'Amico, A. D'Amico, 2003, Journal of the National Cancer Institute.

Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes.

Anthony V D'Amico, Javier Hernandez, Arthur L Burnett, 2007, The Journal of urology.

Prostate-specific antigen as a marker of disease activity in prostate cancer.

Alan W Partin, A. Partin, H. Scher, 2002, Oncology.

PSA progression following radical prostatectomy and radiation therapy: new standards in the new Millennium.

Mesut Remzi, Bob Djavan, J. Moul, 2003, European urology.

A decision aid for teaching limitations of prostate cancer screening.

Robert M Hamm, Kathryn L Taylor, Paul A Godley, 2008, Journal of National Black Nurses' Association : JNBNA.

Population screening for prostate cancer and emerging concepts for young men.

J. Moul, Judd W Moul, 2003, Clinical prostate cancer.

Erectile function outcome reporting after clinically localized prostate cancer treatment.

Anthony V D'Amico, Javier Hernandez, S Larry Goldenberg, 2007, The Journal of urology.

Proteomics in prostate cancer

J. Moul, S. Srivastava, L. Bañez, 2005, Current opinion in urology.

Tumor volume, tumor percentage involvement, or prostate volume: which is predictive of prostate-specific antigen recurrence?

Robin Vollmer, J. Moul, D. Albala, 2010, Urology.

Diagnostic potential of serum proteomic patterns in prostate cancer.

Bao-Ling Adam, Amina Ali, J. Moul, 2003, The Journal of urology.

Comparison of DRE and PSA in the Detection of Prostate Cancer.

J. Moul, Judd W Moul, 2017, The Journal of urology.